SECsense Logo

FibroBiologics, Inc. 8-K Report: Key Corporate Insights & Stock Information

$FBLG
Form 8-K
Filed on: 2024-12-20
Source
FibroBiologics, Inc. 8-K Report: Key Corporate Insights & Stock Information

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: FibroBiologics, Inc.
  • CIK (Central Index Key): 0001958777
  • IRS Employer Identification Number (EIN): 86-3329066
  • Address: 455 E. Medical Center Blvd., Suite 300, Houston, TX 77598
  • Phone Number: (281) 671-5150
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-41934
  • Ticker Symbol: FBLG (traded on NASDAQ)
  1. Filing Type:
  • The filing is an 8-K report, indicating that it is a current report used to announce major events that shareholders should know about.
  1. Date of Filing:
  • The report is dated December 19, 2024.
  1. Stock Information:
  • Common Stock: The report mentions common stock with a par value of $0.00001 per share.
  • The reporting includes shares and USD as the unit of measure, which indicates financial information is presented in both currency and share format.
  1. Context and Measurement:
  • The context of the data is set as of the date December 19, 2024, which indicates that the information is specific to that date.
  • The report uses USD as the currency unit for financial figures.
  1. Schema Reference:
  • The filing references a schema located at "fblg-20241219.xsd," which provides a structure for the data presented in the filing.

Summary

This report is a current event filing for FibroBiologics, Inc. on December 19, 2024, detailing key corporate information, stock details, and filing specifics. It is important for current and potential investors to note the company's trading symbol, address, and the nature of the filing for any significant developments impacting the company.